Published in Oncol Rep on May 22, 2014
The Role of Long Non-Coding RNAs in Ovarian Cancer. Iran Biomed J (2016) 0.84
Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer. Oncotarget (2015) 0.83
An overview of long non-coding RNAs in ovarian cancers. Oncotarget (2016) 0.80
Neighborhood and Family Environment of Expectant Mothers May Influence Prenatal Programming of Adult Cancer Risk: Discussion and an Illustrative DNA Methylation Example. Biodemography Soc Biol (2016) 0.80
Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer. J Exp Clin Cancer Res (2017) 0.79
Long noncoding RNA MEG3, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis. Oncotarget (2017) 0.78
HuR-regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancer. Cancer Med (2016) 0.78
A genomic screen for long noncoding RNA genes epigenetically silenced by aberrant DNA methylation in colorectal cancer. Sci Rep (2016) 0.77
Dysregulated expression of long noncoding RNAs in gynecologic cancers. Mol Cancer (2017) 0.75
Dysregulated Expression of Long Noncoding RNAs in Ovarian Cancer. Int J Gynecol Cancer (2016) 0.75
Improved method for prioritization of disease associated lncRNAs based on ceRNA theory and functional genomics data. Oncotarget (2016) 0.75
Microarray expression profiling of long non-coding RNAs in epithelial ovarian cancer. Oncol Lett (2017) 0.75
Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications. World J Gastroenterol (2017) 0.75